Effect of Hernia Sac Excision on Crural Tension in Paraesophageal Hernia Repair

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorCorewell Health West

About this trial

Paraesophageal hernia can cause significant clinical symptoms, including reflux, chest pain, nausea, regurgitation, and even life threatening conditions such as bowel obstruction, and gastric volvulus. Repair of a paraesophageal hernia is associated with significant recurrence rate, with primary repair often in excess of 50%. Hernia recurrence and revisional surgery significantly increase the likelihood of complications and decreased quality of life.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

All patients age 18-80 undergoing elective or emergent paraesophageal hernia repair for symptomatic paraesophageal hernia will be eligible for enrollment into the study.

Disqualifiers

Patients with previous history of esophageal, gastric, diaphragmatic, or anti-reflux surgery will be excluded.

Trial population

Corewell Health General Surgery Patients

Trial design

Design model

Case-only

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Primary Outcome

Intraoperative Pre and Post hernia sac excision crural tension measurement will be collected.

Time frame
Immediately following procedure

Secondary outcomes

1

Competeness of hernia sac excision

Determining whether the hernia sac excision was complteted or partial

Time frame
Immediately following procedure
2

Paraesophageal hernia type

Comparing the paraesophageal hernia type

Time frame
Immediately following procedure
3

Mesh useage

Comparing the type of mesh used during the procedure

Time frame
Immediately following procedure
4

Complications

Following patients for post-op complications

Time frame
30-days post-op

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.